Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Peptic Ulcer

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    March 2021
  1. DE FRANCESCO V, Zullo A, Manta R, Gatta L, et al
    Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review.
    Eur J Gastroenterol Hepatol. 2021 Mar 19. pii: 00042737-900000000-97264.
    PubMed     Abstract available


  2. MOHAPATRA S, Charilaou P, Korman A
    Not all upper gastrointestinal bleeds in cirrhotics are variceal!
    Eur J Gastroenterol Hepatol. 2021;33:448-450.
    PubMed    


    February 2021
  3. SIRIN G, Sezikli M, Eruyar AT, Dindar G, et al
    Duodenal bulb infection may be a risk factor for Helicobacter pylori eradication insuccess.
    Eur J Gastroenterol Hepatol. 2021;32:303-304.
    PubMed    


    December 2020
  4. STURM L, Muller L, Schultheiss M, Binder B, et al
    Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma.
    Eur J Gastroenterol Hepatol. 2020 Dec 14. doi: 10.1097/MEG.0000000000002018.
    PubMed     Abstract available


    November 2020
  5. RAMACHANDRAN P, Perisetti A, Gajendran M, Jean-Louis F, et al
    Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19.
    Eur J Gastroenterol Hepatol. 2020 Nov 30. doi: 10.1097/MEG.0000000000002013.
    PubMed     Abstract available


  6. HIRAI R, Shimodate Y, Minami M, Ishikawa S, et al
    AIMS65 predicts prognosis of patients with duodenal ulcer bleeding; a comparison with other risk-scoring systems.
    Eur J Gastroenterol Hepatol. 2020 Nov 30. doi: 10.1097/MEG.0000000000002010.
    PubMed     Abstract available


  7. AZIZ M, Dasari CS, Zafar Y, Fatima R, et al
    Does timing of endoscopy affect outcomes in patients with upper gastrointestinal bleeding: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2020 Nov 10. doi: 10.1097/MEG.0000000000001975.
    PubMed     Abstract available


    October 2020
  8. ZHAO S, Ding L, Xie Q, Zhang J, et al
    Is there an association between peptic ulcer disease and osteoporosis: a systematic review and cumulative analysis.
    Eur J Gastroenterol Hepatol. 2020 Oct 29. doi: 10.1097/MEG.0000000000001981.
    PubMed     Abstract available


    September 2020
  9. BALLA A, Leone G, Ribichini E, Sacchi MC, et al
    Gastroesophageal Reflux Disease - Health-Related Quality of Life Questionnaire: prospective development and validation in Italian.
    Eur J Gastroenterol Hepatol. 2020 Sep 9. doi: 10.1097/MEG.0000000000001914.
    PubMed     Abstract available


    August 2020
  10. GHOZ H, Patel P, Stancampiano F, Patel S, et al
    Proton-pump-inhibitor use associated with lower short-term rebleeding and mortality in patients receiving esophageal variceal band ligation: a retrospective cohort study.
    Eur J Gastroenterol Hepatol. 2020 Aug 28. doi: 10.1097/MEG.0000000000001905.
    PubMed     Abstract available


  11. LI H, Xia XJ, Zhang LF, Chi JS, et al
    Comparative study of allicin-containing quadruple therapy vs. bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: a prospective randomized study.
    Eur J Gastroenterol Hepatol. 2020 Aug 14. doi: 10.1097/MEG.0000000000001896.
    PubMed     Abstract available


  12. DIRWEESH A, Anugwom CM, Li Y, Vaughn BP, et al
    Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2020 Aug 4. doi: 10.1097/MEG.0000000000001857.
    PubMed     Abstract available


    July 2020
  13. XU H, Wang W, Ma X, Feng R, et al
    Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis.
    Eur J Gastroenterol Hepatol. 2020 Jul 3. doi: 10.1097/MEG.0000000000001835.
    PubMed     Abstract available


    June 2020
  14. KALKANLI TAS S, Kirkik D, Tanoglu A, Kahraman R, et al
    Polymorphisms in Toll-like receptors 1, 2, 5, and 10 are associated with predisposition to Helicobacter pylori infection.
    Eur J Gastroenterol Hepatol. 2020 Jun 11. doi: 10.1097/MEG.0000000000001797.
    PubMed     Abstract available


  15. KHAN MY, Aslam A, Mihali AB, Shabbir Rawala M, et al
    Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2020;32:686-694.
    PubMed     Abstract available


    May 2020
  16. IKEDA R, Hirasawa K, Sato C, Sawada A, et al
    Incidence of metachronous gastric cancer after endoscopic submucosal dissection associated with eradication status of Helicobacter pylori.
    Eur J Gastroenterol Hepatol. 2020 May 29. doi: 10.1097/MEG.0000000000001788.
    PubMed     Abstract available


  17. KHAN MY, Aslam A, Mihali AB, Shabbir Rawala M, et al
    Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2020 May 2. doi: 10.1097/MEG.0000000000001740.
    PubMed     Abstract available


    April 2020
  18. KAMAL F, Khan MA, Tariq R, Ismail MK, et al
    Systematic review and meta-analysis: monopolar hemostatic forceps with soft coagulation in the treatment of peptic ulcer bleeding.
    Eur J Gastroenterol Hepatol. 2020 Apr 20. doi: 10.1097/MEG.0000000000001738.
    PubMed     Abstract available


    January 2020
  19. ZULLO A
    The current role of dual therapy for treatment of Helicobacter pylori: back to the future?
    Eur J Gastroenterol Hepatol. 2020 Jan 8. doi: 10.1097/MEG.0000000000001654.
    PubMed    


    December 2019
  20. ZHANG Y, Zhu YJ, Zhao Z, Zhao JT, et al
    Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial.
    Eur J Gastroenterol Hepatol. 2019 Dec 16. doi: 10.1097/MEG.0000000000001646.
    PubMed     Abstract available


    November 2019
  21. CHEN C, Zhang C, Wang X, Zhang F, et al
    Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.
    Eur J Gastroenterol Hepatol. 2019 Nov 7. doi: 10.1097/MEG.0000000000001601.
    PubMed     Abstract available


    October 2019
  22. DURICEK M, Banovcin P Jr, Halickova T, Hyrdel R, et al
    Comprehensive analysis of acidic pharyngeal reflux before and after proton pump inhibitor treatment in patients with suspected laryngopharyngeal reflux.
    Eur J Gastroenterol Hepatol. 2019 Oct 30. doi: 10.1097/MEG.0000000000001584.
    PubMed     Abstract available


    September 2019
  23. LI Y, Li H, Zhu Q, Tsochatzis E, et al
    Effect of acute upper gastrointestinal bleeding manifestations at admission on the in-hospital outcomes of liver cirrhosis: hematemesis versus melena without hematemesis.
    Eur J Gastroenterol Hepatol. 2019 Sep 11. doi: 10.1097/MEG.0000000000001524.
    PubMed     Abstract available


    August 2019
  24. JANKA T, Tornai T, Borbely B, Tornai D, et al
    Deleterious effect of proton pump inhibitors on the disease course of cirrhosis.
    Eur J Gastroenterol Hepatol. 2019 Aug 27. doi: 10.1097/MEG.0000000000001499.
    PubMed     Abstract available


  25. KAPIZIONI C, Koutoufaris G, Ntouli V, Makris K, et al
    Optimal duration of concomitant nonbismuth quadruple therapy as first-line therapy for Helicobacter pylori: a prospective, open-label, comparative study.
    Eur J Gastroenterol Hepatol. 2019 Aug 20. doi: 10.1097/MEG.0000000000001517.
    PubMed     Abstract available


  26. KAWADA T
    Sex difference in patients with Helicobacter pylori infection.
    Eur J Gastroenterol Hepatol. 2019;31:1070.
    PubMed    


    April 2019
  27. JUNG DH, Ko BS, Kim YJ, Kim WY, et al
    Comparison of risk scores and shock index in hemodynamically stable patients presenting to the emergency department with nonvariceal upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2019 Apr 18. doi: 10.1097/MEG.0000000000001422.
    PubMed     Abstract available


  28. NING L, Liu R, Lou X, Du H, et al
    Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2019 Apr 3. doi: 10.1097/MEG.0000000000001398.
    PubMed     Abstract available


    March 2019
  29. FERRO A, Morais S, Pelucchi C, Dierssen-Sotos T, et al
    Sex differences in the prevalence of Helicobacter pylori infection: an individual participant data pooled analysis (StoP Project).
    Eur J Gastroenterol Hepatol. 2019 Mar 4. doi: 10.1097/MEG.0000000000001389.
    PubMed     Abstract available


    February 2019
  30. LAI SW, Lin CL, Liao KF
    Proton pump inhibitors therapy and the risk of major osteoporotic nonhip fractures in older adults in Taiwan.
    Eur J Gastroenterol Hepatol. 2019;31:272-273.
    PubMed    


    November 2018
  31. ISLAM MM, Poly TN, Walther BA, Dubey NK, et al
    Response to letter: 'Proton pump inhibitors therapy and the risk of major osteoporotic nonhip fractures in older adults in Taiwan'.
    Eur J Gastroenterol Hepatol. 2018 Nov 19. doi: 10.1097/MEG.0000000000001309.
    PubMed    


    September 2018
  32. WILKINSON J, Wade A, Thomas SJ, Jenner B, et al
    Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
    Eur J Gastroenterol Hepatol. 2018 Sep 27. doi: 10.1097/MEG.0000000000001258.
    PubMed     Abstract available


    July 2018
  33. ISLAM MM, Poly TN, Walther BA, Dubey NK, et al
    Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Jul 19. doi: 10.1097/MEG.0000000000001198.
    PubMed     Abstract available


  34. JARUVONGVANICH V, Poonsombudlert K, Ungprasert P
    Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Jul 6. doi: 10.1097/MEG.0000000000001204.
    PubMed     Abstract available


    June 2018
  35. TALEBI BEZMIN ABADI A, Yamaoka Y
    Call for shift in Helicobacter pylori treatment.
    Eur J Gastroenterol Hepatol. 2018;30:687.
    PubMed    


    April 2018
  36. PONZETTO A, Figura N
    Helicobacter pylori infection among patients with liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2018;30:490.
    PubMed    


    March 2018
  37. KHAN MY, Siddiqui WJ, Alvarez C, Aggarwal S, et al
    Reduction in postpercutaneous coronary intervention angina in addition to gastrointestinal events in patients on combined proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Mar 28. doi: 10.1097/MEG.0000000000001125.
    PubMed     Abstract available


  38. PELLICANO R, Durazzo M
    Helicobacter pylori among patients with uninvestigated dyspepsia: issues to be remembered.
    Eur J Gastroenterol Hepatol. 2018;30:278-279.
    PubMed    


    February 2018
  39. FIORINI G, Zullo A, Saracino IM, Gatta L, et al
    Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
    Eur J Gastroenterol Hepatol. 2018 Feb 23. doi: 10.1097/MEG.0000000000001102.
    PubMed     Abstract available


  40. XAVIER SA, Vilas-Boas R, Boal Carvalho P, Magalhaes JT, et al
    Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2018 Feb 12. doi: 10.1097/MEG.0000000000001087.
    PubMed     Abstract available


    November 2017
  41. SUKI M, Leibovici Weissman Y, Boltin D, Itskoviz D, et al
    Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study.
    Eur J Gastroenterol Hepatol. 2017 Nov 8. doi: 10.1097/MEG.0000000000001014.
    PubMed     Abstract available


  42. PELLICANO R
    Helicobacter pylori among patients with cirrhosis: incidence or prevalence?
    Eur J Gastroenterol Hepatol. 2017;29:1315.
    PubMed    


    September 2017
  43. BARAN M, Cagan Appak Y, Karakoyun M, Yalcinkaya S, et al
    The overlap of gastroesophageal reflux disease and functional constipation in children: the efficacy of constipation treatment.
    Eur J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1097/MEG.0000000000000979.
    PubMed     Abstract available


  44. COSTA S, Soares JB, Goncalves R
    Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.
    Eur J Gastroenterol Hepatol. 2017 Sep 4. doi: 10.1097/MEG.0000000000000960.
    PubMed     Abstract available


    August 2017
  45. MALMI H, Kautiainen H, Virta LJ, Farkkila MA, et al
    Outcomes of patients hospitalized with peptic ulcer disease diagnosed in acute upper endoscopy.
    Eur J Gastroenterol Hepatol. 2017 Aug 29. doi: 10.1097/MEG.0000000000000951.
    PubMed     Abstract available


  46. SIECZKOWSKA A, Landowski P, Zagozdzon P, Kaminska B, et al
    The association of proton pump inhibitor therapy and small bowel bacterial overgrowth in children.
    Eur J Gastroenterol Hepatol. 2017 Aug 10. doi: 10.1097/MEG.0000000000000946.
    PubMed    


    July 2017
  47. ZHOU YJ, Zheng JN, Zhou YF, Han YJ, et al
    Development of a prognostic nomogram for cirrhotic patients with upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2017 Jul 25. doi: 10.1097/MEG.0000000000000943.
    PubMed     Abstract available


  48. POGORZELSKA J, Lapinska M, Kalinowska A, Lapinski TW, et al
    Helicobacter pylori infection among patients with liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2017 Jul 11. doi: 10.1097/MEG.0000000000000928.
    PubMed     Abstract available


  49. JENSEN BES, Hansen JM, Larsen KS, Junker AB, et al
    Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy.
    Eur J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1097/MEG.0000000000000934.
    PubMed     Abstract available


    June 2017
  50. VIAZIS N, Katopodi K, Karamanolis G, Denaxas K, et al
    Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
    Eur J Gastroenterol Hepatol. 2017 Jun 16. doi: 10.1097/MEG.0000000000000925.
    PubMed     Abstract available


    May 2017
  51. FILL MALFERTHEINER S, Seelbach-Gobel B, Costa SD, Ernst W, et al
    Impact of gastroesophageal reflux disease symptoms on the quality of life in pregnant women: a prospective study.
    Eur J Gastroenterol Hepatol. 2017 May 3. doi: 10.1097/MEG.0000000000000905.
    PubMed     Abstract available


  52. SMITH S, Boyle B, Brennan D, Buckley M, et al
    The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
    Eur J Gastroenterol Hepatol. 2017;29:552-559.
    PubMed     Abstract available


    April 2017
  53. PELLICANO R, Fagoonee S
    Any role for proton pump inhibitors in the relationship between new erosive oesophagitis and abdominal visceral fat?
    Eur J Gastroenterol Hepatol. 2017;29:489.
    PubMed    


  54. NAM SY, Kim YW, Park BJ, Ryu KH, et al
    Effect of abdominal visceral fat on the development of new erosive oesophagitis: a prospective cohort study.
    Eur J Gastroenterol Hepatol. 2017;29:388-395.
    PubMed     Abstract available


    February 2017
  55. ROYSTON C, Bardhan KD
    Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.
    Eur J Gastroenterol Hepatol. 2017 Feb 1. doi: 10.1097/MEG.0000000000000845.
    PubMed     Abstract available


    January 2017
  56. SMITH S, Boyle B, Brennan D, Buckley M, et al
    The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
    Eur J Gastroenterol Hepatol. 2017 Jan 10. doi: 10.1097/MEG.0000000000000822.
    PubMed     Abstract available


    December 2016
  57. CARES K, Al-Ansari N, Macha S, Zoubi N, et al
    Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children.
    Eur J Gastroenterol Hepatol. 2016 Dec 27. doi: 10.1097/MEG.0000000000000815.
    PubMed     Abstract available


    November 2016
  58. UPALA S, Sanguankeo A, Saleem SA, Jaruvongvanich V, et al
    Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Abstract available


    September 2016
  59. STROMDAHL M, Helgeson J, Kalaitzakis E
    Emergency readmission following acute upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Abstract available


    May 2016
  60. JEE SR, Park MI, Lim SK, Kim SE, et al
    Clinical impact of second-look endoscopy after endoscopic submucosal dissection of gastric neoplasm: a multicenter prospective randomized-controlled trial.
    Eur J Gastroenterol Hepatol. 2016;28:546-52.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: